Alan D Frazier - Net Worth and Insider Trading
Alan D Frazier Net Worth
The estimated net worth of Alan D Frazier is at least $16,845 dollars as of 2024-11-08. Alan D Frazier is the Director of Rigel Pharmaceuticals Inc and owns about 1,091 shares of Rigel Pharmaceuticals Inc (RIGL) stock worth over $16,845. Details can be seen in Alan D Frazier's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Alan D Frazier has not made any transactions after 2005-01-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Alan D Frazier
Alan D Frazier Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Alan D Frazier owns 6 companies in total, including AnaptysBio Inc (ANAB) , Sierra Oncology Inc (SRRA) , and Glaukos Corp (GKOS) among others .
Click here to see the complete history of Alan D Frazier’s form 4 insider trades.
Insider Ownership Summary of Alan D Frazier
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ANAB | AnaptysBio Inc | 2017-01-25 | 10 percent owner |
| SRRA | Sierra Oncology Inc | 2017-02-14 | 10 percent owner |
| GKOS | Glaukos Corp | 2015-06-24 | 10 percent owner |
 | | 2015-05-06 | 10 percent owner |
| | 2011-07-28 | director |
| | 2005-01-25 | director |
Alan D Frazier Latest Holdings Summary
Alan D Frazier currently owns a total of 1 stock. Alan D Frazier owns 1,091 shares of Rigel Pharmaceuticals Inc (RIGL) as of January 25, 2005, with a value of $16,845.
Latest Holdings of Alan D Frazier
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RIGL | Rigel Pharmaceuticals Inc | 2005-01-25 | 1,091 | 15.44 | 16,845 |
Holding Weightings of Alan D Frazier
Alan D Frazier Form 4 Trading Tracker
According to the SEC Form 4 filings, Alan D Frazier has made a total of 0 transactions in Rigel Pharmaceuticals Inc (RIGL) over the past 5 years. The most-recent trade in Rigel Pharmaceuticals Inc is the sale of 233 shares on January 25, 2005, which brought Alan D Frazier around $44,541.
Insider Trading History of Alan D Frazier
- 1
Alan D Frazier Trading Performance
Alan D Frazier Ownership Network
Ownership Network List of Alan D Frazier
Ownership Network Relation of Alan D Frazier
Alan D Frazier Owned Company Details
What does AnaptysBio Inc do?
Who are the key executives at AnaptysBio Inc?
Alan D Frazier is the 10 percent owner of AnaptysBio Inc. Other key executives at AnaptysBio Inc include Chief Medical Officer Paul F. Lizzul , General Counsel Eric J Loumeau , and Chief Financial Officer Dennis Mulroy .
AnaptysBio Inc (ANAB) Insider Trades Summary
Over the past 18 months, Alan D Frazier made no insider transaction in AnaptysBio Inc (ANAB). Other recent insider transactions involving AnaptysBio Inc (ANAB) include a net sale of 11,879 shares made by Paul F. Lizzul , a net sale of 26,687 shares made by Eric J Loumeau , and a net sale of 24,965 shares made by Dennis Mulroy .
In summary, during the past 3 months, insiders sold 30,440 shares of AnaptysBio Inc (ANAB) in total and bought 273,972 shares, with a net purchase of 243,532 shares. During the past 18 months, 233,237 shares of AnaptysBio Inc (ANAB) were sold and 273,972 shares were bought by its insiders, resulting in a net purchase of 40,735 shares.
AnaptysBio Inc (ANAB)'s detailed insider trading history can be found in Insider Trading Tracker table.
AnaptysBio Inc Insider Transactions
Alan D Frazier Mailing Address
Above is the net worth, insider trading, and ownership report for Alan D Frazier. Currently GuruFocus does not have mailing address information for Alan D Frazier.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
